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The diversity of MTOR-regulated mRNA translation remains unresolved. Whereas ribosome-profiling suggested that
MTOR almost exclusively stimulates translation of the TOP (terminal oligopyrimidine motif) and TOP-like mRNAs, poly-
some-profiling indicated that MTOR also modulates translation of mRNAs without the 5′ TOP motif (non-TOP mRNAs).
We demonstrate that in ribosome-profiling studies, detection of MTOR-dependent changes in non-TOPmRNA translation
was obscured by low sensitivity and methodology biases. Transcription start site profiling using nano-cap analysis of gene
expression (nanoCAGE) revealed that not only do many MTOR-sensitive mRNAs lack the 5′ TOP motif but that 5′ UTR
features distinguish two functionally and translationally distinct subsets of MTOR-sensitive mRNAs: (1) mRNAs with short
5′ UTRs enriched for mitochondrial functions, which require EIF4E but are less EIF4A1-sensitive; and (2) long 5′ UTR
mRNAs encoding proliferation- and survival-promoting proteins, which are both EIF4E- and EIF4A1-sensitive. Selective in-
hibition of translation of mRNAs harboring long 5′ UTRs via EIF4A1 suppression leads to sustained expression of proteins
involved in respiration but concomitant loss of those protecting mitochondrial structural integrity, resulting in apoptosis.
Conversely, simultaneous suppression of translation of both long and short 5′ UTRmRNAs by MTOR inhibitors results in
metabolic dormancy and a predominantly cytostatic effect. Thus, 5′ UTR features define different modes of MTOR-sensi-
tive translation of functionally distinct subsets of mRNAs, which may explain the diverse impact of MTOR and EIF4A in-
hibitors on neoplastic cells.
[Supplemental material is available for this article.]
Genome-wide gene expression studies have mostly focused on
measuring “steady-state” mRNA abundance that reflects alter-
ations in transcription and mRNA stability (Piccirillo et al. 2014).
Changes in steady-state mRNA abundance do not, however,
completely mirror those occurring in the corresponding proteome
(Gygi et al. 1999; de Sousa Abreu et al. 2009; Larsson et al. 2012;
Kristensen et al. 2013; Ly et al. 2014). Although still debated (Li
and Biggin 2015), these studies implicate post-transcriptional
mechanisms, including mRNA translation, as key influencers
over the proteome (Schwanhausser et al. 2011; Vogel and
Marcotte 2012; Kristensen et al. 2013; Li et al. 2014; Jovanovic
et al. 2015).
Control of translation largely occurs at the initiation step,
during which the mRNA is recruited to the ribosome by the
eIF4F complex (Hinnebusch 2014). This complex consists of the
mRNA cap-binding protein EIF4E, a large scaffolding protein
EIF4G, and DEAD box helicase EIF4A (Hinnebusch 2014). eIF4F
complex assembly is regulated by the mechanistic/mammalian
target of rapamycin (mTOR) complex 1 (mTORC1), which phos-
phorylates and inactivates 4E-binding proteins (EIF4EBP1, 2, and
3) (von Manteuffel et al. 1996; Hara et al. 1997; Burnett et al.
1998; Gingras et al. 1999, 2001). EIF4EBPs bind to EIF4E, thereby
preventing EIF4E:EIF4G association (Pause et al. 1994a).
Phosphorylation of EIF4EBPs leads to their dissociation from
EIF4E, allowing EIF4E:EIF4G interaction and eIF4F assembly
(Gingras et al. 1999, 2001). Although EIF4E is required for cap-de-
pendent translation of all nuclear-encoded mRNAs, a subset of
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mRNAs characterized by long and complex 5′ UTRs that encode
proliferation- (e.g., cyclins), survival- (e.g., BCL2 familymembers),
and tumor-promoting proteins (e.g., MYC) are thought to be par-
ticularly sensitive to EIF4E (Koromilas et al. 1992; Graff et al. 2008;
Roux and Topisirovic 2012; Pelletier et al. 2015).
UTR features dictate translation efficiency (Sonenberg
and Hinnebusch 2009). In mammals, mRNAs with long, complex
5′ UTRs exhibit a high EIF4A helicase requirement for scanning of
43S complex toward the initiation codon (Svitkin et al. 2001).
EIF4A processivity, as a single protein, is low (Pause et al.
1994b). EIF4A:EIF4G interaction dramatically increases EIF4A
processivity (Garcia-Garcia et al. 2015). EIF4E recruits EIF4A to
the eIF4F complex, thereby bolstering EIF4A activity (Feoktistova
et al. 2013). Recent ribosome-profiling studies indicate that the
mTORC1/EIF4EBP/EIF4E pathway almost exclusively regulates
translation of mRNAs harboring 5′ terminal oligopyrimidine (5′
TOP) and related motifs (Hsieh et al. 2012; Thoreen et al. 2012).
The 5′ TOP motif consists of a C immediately after the mRNA
cap, followed by 4–15 pyrimidines (Meyuhas and Kahan 2015).
TOPmRNAs encode translationalmachinery components, includ-
ing ribosomal proteins and elongation factors (Meyuhas and
Kahan 2015).
The generality of the conclusions that EIF4EBPs aremajor reg-
ulators of TOP mRNA translation has been questioned, because
under a number of conditions, translation of TOP mRNAs, albeit
MTOR-dependent, is EIF4EBP-independent (Miloslavski et al.
2014). Consistent with this view, the effects of serum deprivation
on TOP mRNA translation also appeared to be EIF4E-independent
(Shama et al. 1995). In turn, LARP1 and TIA1/TIAL1 (also known
as TIAR) were reported to mediate effects of mTORC1 on TOP
mRNAs (Damgaard and Lykke-Andersen 2011; Tcherkezian et al.
2014; Fonseca et al. 2015). Polysome-profiling showed that the
mTORC1/EIF4EBP axis also regulates translation of non-TOP
mRNAs, including those encoding mitochondrial and survival-
and proliferation-promoting proteins (Larsson et al. 2012; Morita
et al. 2013). In fact, it appears that ribosome- and polysome-profil-
ing studies provided strikingly different sets of MTOR-sensitive
mRNAs.
Elucidating the precise mechanisms that control mRNA
translation also requires accurate knowledge of transcription start
sites (TSSs). Despite substantial efforts to define TSSs using CAGE/
nanoCAGE (The FANTOM Consortium and the RIKEN PMI and
CLST [DGT] 2014) or TSS-seq (Suzuki and Sugano 2003; Suzuki
et al. 2015), there are no resources that provide TSS information
for the most commonly used model cell lines. Databases such as
RefSeq or UCSC are thus routinely used to infer the link between
5′ UTR features and translation. These databases are thought to
contain numerous errors, and for a more accurate understanding
of the relationship between the 5′ UTR features and translational
control, both TSSs and translation efficiency should be determined
in the same cell.
Results
Simulating the impact of differences in polysome
association on performance of ribosome-
and polysome-profiling
Wecompared ribosome- and polysome-profiling for their ability to
identify mRNAs undergoing different shifts in translational effi-
ciency. In polysome-profiling, translation efficiency is directly de-
termined by separating efficiently (commonly defined as mRNAs
associated with more than three ribosomes) and not efficiently
translated mRNAs (defined as mRNAs associated with three or
less ribosomes) (Gandin et al. 2014). In contrast, with ribosome-
profiling translational efficiency is inferred based on the number
of RNA sequencing reads corresponding to ribosome-protected
fragments (Gandin et al. 2014; Ingolia 2014; King and Gerber
2014). TOP mRNAs are highly expressed (Fig. 1A,B), engage a con-
siderable proportion of cellular ribosomes when MTOR is active
(Levy et al. 1991; Meyuhas and Kahan 2015; Miloslavski et al.
2014), and show large shifts in translational efficiency upon
MTOR inhibition, as compared to mRNAs that do not contain a
5′ TOP motif (non-TOP mRNAs) (Supplemental Fig. 1; Levy et al.
1991; Miloslavski et al. 2014).
We therefore determined performance of ribosome- vs. poly-
some-profiling in identifying differentially translated mRNAs as
a function of the size of shifts in translational efficiency using a
simulation approach. Suitable parameters for simulation were ob-
tained by comparisons of modeled normal distributions of ribo-
some association converted to sedimentation distances (Fig. 1C)
to experimentally determined ribosome associations in insulin-
vs. insulin + torin1-treated MCF7 cells (Supplemental Fig. 2A–C).
Using these parameters, we then modeled a range of shifts in
control vs. MTOR inhibition conditions (Fig. 1D) and estimated
the mean number of ribosomes per mRNA (i.e., ribosome-profil-
ing) (Ingolia et al. 2009; Ingolia 2014) or the proportion of the
mRNAs that are associated with more than three ribosomes (i.e.,
polysome-profiling) (Larsson et al. 2012). We calculated fold-
change differences and their p-values (control vs. MTOR inhibi-
tion) for each shift, for both polysome- and ribosome-profiling
simulations. Because equal proportions of all shifts were represent-
ed in the simulation, the proportion of each shift among the small-
est P-values or largest fold changes is expected to be the same.
Using P-value-based ranking, polysome-profiling appeared not to
be affected by the size of the shift in polysome association, while
ribosome-profiling was biased toward identifying mRNAs that ex-
hibit larger shifts (Fig. 1E–G). Similar bias was observed for poly-
some-profiling when fold-change analysis was employed, but
polysome-profiling still outperformed ribosome-profiling (Fig.
1H,I). These analyses were stable inasmuch asmodifying the simu-
lation parameters did not alter the outcome (Supplemental Fig. 3).
Using the same approach, we compared performance of ribo-
some- vs. polysome-profiling in identifying changes of non-TOP
vs. TOP mRNA translation as a function of MTOR activity.
Parameters were determined from experimentally tested TOP and
non-TOP mRNAs (Supplemental Figs. 1, 2). Shifts to sub-80S frac-
tions cannot be modeled using normal distributions, and the
mean of the distribution under MTOR inhibition was therefore
set to one ribosome.While polysome-profiling identified expected
equal proportions of TOP and non-TOPmRNAs among genes with
the lowest P-values, ribosome-profiling again favored identifica-
tion of TOP mRNAs as differentially translated (Supplemental
Fig. 4A). Analysis based on fold changes showed bias for identifica-
tion of TOP mRNAs over non-TOP mRNAs as differentially trans-
lated for both polysome- and ribosome-profiling, but the bias
toward identifying TOPmRNAs as differentially translated was still
less pronounced for polysome-profiling (Supplemental Fig. 4B,C).
Thus, ribosome-profiling shows a bias which favors identification
of mRNAs that exhibit larger shifts in polysomes as translationally
regulated, which is the case for TOP mRNAs after modulation of
MTOR activity.
Gene expression is commonly quantified by relative rather
than absolute measurements. Accordingly, changes in each
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Figure 1. Biases in polysome- and ribosome-profiling studies of translation efficiency. (A,B) Mean expression levels and densities according to data from
poly(A)+ RNA formRNAs identified as differentially translated by ribosome-profiling (Hsieh et al. 2012; Thoreen et al. 2012), which include∼60%–70%TOP
mRNAs; polysome-profiling (Larsson et al. 2012), which includes ∼10% TOPmRNAs; and nonmovers. Percentage of mRNAs and mean reads per kilobase
per million mapped reads (RPKM) per subset is indicated. (C) Calculated relationship between number of bound ribosomes and sedimentation in a
5%–50% sucrose gradient. (D) Simulated distributions of ribosome association under a condition whenMTOR is inhibited (black) and a range of ribosome
association under the control condition. (E,H) Proportions of differentially translated mRNAs identified by polysome- or ribosome-profiling simulations
from analyzed shifts in polysome association. Genes were ranked by P-value (E) or fold change (H). (F,I) Observed bias (i.e., obtained percentage of genes
from each shift compared to expected percentage) across all shifts. (G) Sums of bias across all shifts for each technology and analysis approach. (F,G,I)
Means and standard deviations from four replicated simulations are shown. (J,K ) Observed absolute or relative fold changes using polysome- or ribosome-
profiling for TOP and non-TOP mRNAs under conditions when an increasing proportion of TOP mRNAs change their translation (J) or when global trans-
lation is affected (K ).
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specific mRNA translation are measured in relation to the mean
effect on translation of all mRNAs. To account for this, we per-
formed simulations using relative translation efficacies and in-
cluded invariant mRNAs (i.e., those mRNAs that did not appear
to change significantly their translation in response to MTOR in-
hibition in both ribosome- [Hsieh et al. 2012] and polysome-pro-
filing studies [Larsson et al. 2012], hereafter referred to as
“nonmovers”). Simulation parameters for ribosome association
for nonmovers were obtained by fitting a normal distribution to
the polysome-profile (Supplemental Fig. 2A). Changes in transla-
tion were then simulated as described above for TOP and non-
TOP mRNAs while including nonmovers. We assessed how in-
creasing the proportion of TOP mRNAs that changed their trans-
lation impacts predicted fold changes for TOP- and non-TOP
mRNAs. This was done before and after normalization by global
centering (which is equivalent to an absolute and relative assess-
ment of effects on translation, respectively). For relative measure-
ments, when an increased proportion of TOP mRNAs were
differentially translated, there was an underestimation of the
fold changes for both TOP and non-TOP mRNAs (Fig. 1J). This ef-
fect was more pronounced for ribosome-profiling, e.g., if ∼3.5% of
all mRNAs are TOP mRNAs and they changed translation, non-
TOP mRNAs will show a less than twofold difference, which is a
commonly used threshold.
AsMTOR inhibition also involves a global down-regulationof
protein synthesis (Roux and Topisirovic 2012), we assessed how
this would impact on TOP and non-TOP mRNA translation. For
this simulation we used the parameters identified for abundance
and proportions of TOP mRNAs, non-TOP mRNAs, and non-
movers (Fig. 1A), and gradually introduced a reduction in transla-
tion for nonmover mRNAs to simulate reduction in global protein
synthesis caused by MTOR inhibition (Fig. 1K). In this case, as
above, non-TOP mRNAs exhibited a less than twofold change
when ribosome-profiling was simulated. Altogether, methodolog-
ical features of ribosome-profiling introduce a bias that obscures
identification of changes in non-TOP mRNA translation. This is
because non-TOP mRNAs show smaller shifts and lower abun-
dance and are thereforemore sensitive to global changes in protein
synthesis as compared to TOPmRNAs. This is likely a key factor un-
derpinning the discrepancies between the repertoires of MTOR-
regulated mRNAs observed in ribosome- vs. polysome-profiling
studies.
Low sensitivity limits the catalog of MTOR-sensitive mRNAs
identified by ribosome-profiling
Optimal RNA-seq depth under control conditions (i.e., vehicle- or
mock-treated cells) is a prerequisite to identify a reduction in trans-
lation induced by a treatment (Larsson and Nadon 2013). We ob-
served that <2000 genes consistently had >256 ribosome-profiling
counts in the control condition (Supplemental Fig. 5A) across the
two replicates reported in Hsieh et al. (2012). Indeed, low read
counts strongly influenced the signal to variance relationship,
and the variance strongly increased at <64 reads (Supplemental
Figs. 5B, 6A). Using edgeR analysis (see below), we observed that
the vast majority of MTOR-sensitive mRNAs did not shift below
the <64-read threshold upon MTOR inhibition (Supplemental
Fig. 5B). This suggests that only abundant mRNAs (e.g., TOP
mRNAs) (Fig. 1A,B) would be identified as being translationally
suppressed by MTOR inhibitors (MTOR-i) in this study (Hsieh
et al. 2012). Indeed, <10% of non-TOPmRNAs, identified as being
MTOR-sensitive in a polysome-profiling study (Larsson et al.
2012), consistently obtained >256 ribosome-profiling counts in
the control condition inHsieh et al. (2012). Alternative algorithms
corroborated these findings (Supplemental Fig. 6B). A second ribo-
some-profiling data set investigating MTOR-sensitive translation
(Thoreen et al. 2012) also suffered from this type of low sensitivity
and could not identify non-TOP mRNAs as being differentially
translated (Supplemental Figs. 5C,D, 7A,B). Thus, despite the dif-
ferences in cell lines and conditions that were used in respective
studies (Hsieh et al. 2012; Larsson et al. 2012; Thoreen et al.
2012), discrepancies in the observed effects of MTOR-i on the
translatome between ribosome- and polysome-profiling studies
appear to stem from technical biases and the low sensitivity in ri-
bosome-profiling studies, and our simulation analysis indicates
that, in addition to TOP mRNAs, MTOR regulates translation of
non-TOP mRNAs.
nanoCAGE identifies subsets of MTOR-sensitive
non-TOP mRNAs that differ in 5′ UTR features
and functions
The above analysis indicates that other 5′ UTR features beyond
5′ TOP motifs must render mRNA translation MTOR-sensitive.
We employed nanoCAGE sequencing (Salimullah et al. 2011) to
map TSSs and 5′ UTRs to investigate this hypothesis (Fig. 2A).
When we reached a sequencing “plateau,” where few additional
genes or TSSs were identified upon additional sequencing (Fig.
2B), we had obtained 5′ UTR sequence information for ∼12,000
RefSeq transcripts, corresponding to ∼6500 genes in MCF7 cells
maintained under the control, mock-treatment condition used
when examining MTOR-sensitive translation by polysome-profil-
ing (Supplemental Table S1; Larsson et al. 2012). Examination of
a selection of TOPmRNAs showed that nanoCAGE accurately cap-
tured TSSs giving rise to mRNAs with TOP motifs also when these
were located downstream from the TSS suggested by RefSeq (Fig.
2C). TSSs identified by nanoCAGE confirmed that most of the
MTOR-regulated mRNAs identified by polysome-profiling
(PP242-sensitive) (Larsson et al. 2012) do not contain a 5′ TOPmo-
tif (∼90%) (Fig. 2D).
Determination of 5′ UTR lengths using the most prevalent
peak length (i.e., the length suggested by the position with the
most RNA-seq reads) or the weighted mean length (allowing
all RNA-seq reads to contribute to a mean) revealed that ∼30%
5′ UTRs identified by nanoCAGE were half the length or shorter
than those described in the RefSeq database (Fig. 2E,F;
Supplemental Fig. 8A,B). Among the MTOR-sensitive mRNAs
identified by polysome-profiling, the TSSs determined by
nanoCAGE, but not RefSeq, indicated a set of transcripts with ex-
tremely short 5′ UTRs (<30 nucleotides [nt]). This set was enriched
in mRNAs encoding proteins with mitochondrial functions (e.g.,
ATP5O, ATP5G1) (Fig. 3A,B), with one exception, RDH13, which
had a long 5′ UTR. These were in stark contrast to cell cycle- and
survival-promoting mRNAs with long 5′ UTRs (e.g., CCND3,
ODC1, MCL1, BIRC5 [survival] and MYC) (Fig. 3C). mRNAs with
short 5′ UTRs, encoding proteins with mitochondrial function,
were enriched (4.7-fold enrichment, P = 0.03) for translation initi-
ator of short 5′ UTR (TISU) elements (Fig. 3D,E; Elfakess et al.
2011). Thus, in addition to TOP mRNAs, MTOR-sensitive mRNAs
include non-TOP mRNAs with long 5′ UTRs, which encode prolif-
eration- and survival-promoting proteins, and a subset of mRNAs
with short (<30 nt) 5′ UTRs that were enrichedwith TISU elements
(Fig. 3A–E).
5 ′ UTR features of MTOR-sensitive mRNAs
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Expression of proteins encoded by a subset of MTOR-sensitive
mRNAs harboring short 5′ UTRs requires EIF4E but is largely
unaffected by EIF4A1
TISUelements rendermRNA translation sensitive toMTORbutnot
to EIF4A inhibition (Elfakess et al. 2011). We therefore depleted
EIF4E or EIF4A1 in MCF7 and HEK293E cells and monitored ex-
pression of proteins encoded by MTOR-sensitive mRNAs with ei-
ther long (CCND3, MCL1, BIRC5, and BCL2) or short (ATP5O,
ATP5G1, NDUFS6, and UQCC2) 5′ UTRs. Whereas EIF4E depletion
decreased expression of both subsets of proteins, reduction in
EIF4A1 selectively affected proteins encoded by long 5′ UTR
mRNAs(Fig.4A;Supplemental Fig.10A).Wereplicated these results
using the active-site MTOR-i torin1 and two chemically distinct
EIF4A inhibitors (EIF4A-i), hippuristanol and silvestrol (Bordeleau
et al. 2005, 2006, 2008). As expected, treatment with torin1 abol-
ished mTORC1 signaling (Thoreen et al. 2009; Galicia-Vazquez
et al. 2012), whereas hippuristanol slightly induced mTORC1
activity as illustrated by changes in EIF4EBP1 andRPS6phosphory-
lation (Supplemental Fig. 10B). Torin1 increased EIF4E:EIF4EBP1
andreducedEIF4E:EIF4G1binding. Incontrast, EIF4E:EIF4G1asso-
ciation was unaffected by hippuristanol (Supplemental Fig. 10C).
Thus, as noted following depletion of EIF4E, torin1 reduced ex-
pression of proteins encoded by both short and long 5′ UTR
MTOR-sensitivemRNAs,whereas EIF4A-i selectively down-regulat-
ed proteins encoded by long 5′ UTR mRNAs (Supplemental Fig.
10B). These effects appeared to bemediated by the EIF4A1 isoform,
as EIF4A2depletion failed to decrease expressionofCCND3,which
is encoded by a prototypical long 5′ UTRmRNA (Supplemental Fig.
10D). As observed previously, EIF4A1 depletion led to an increase
in EIF4A2 levels (Supplemental Fig. 10D; Galicia-Vazquez et al.
2012).Collectively, these results demonstrate that EIF4A1 regulates
expression of proteins encoded by a subset of MTOR-sensitive
mRNAs harboring long, but not short, 5′ UTRs.
Figure 2. Transcription start site analysis using nanoCAGE confirms that MTOR regulates translation of non-TOP mRNAs. (A) The nanoCAGE procedure
to identify transcription start sites (TSS). (BC, barcode; SP, spacer;MS-RanN6, randomhexamer;MS-Dir1R/F, primers for semisuppressive PCR;MS-Dir2R/F,
primers for adaptor PCR). (B) A comparison of the number of identified peaks (more than five reads; left) and RefSeq mRNAs (>50 reads; right) under in-
creasing number of sampled nanoCAGE sequencing reads. (C ) TSS revealed by nanoCAGE in two TOP mRNAs. The UTR lengths suggested by the three
major TSS peaks are indicated together with the 5′ UTR region according to RefSeq and the position of the 5′ TOP motif. (D) The proportion of MTOR-
sensitive (by polysome-profiling) mRNAs with TOP elements according to nanoCAGE. (E,F) A comparison between 5′ UTR lengths according to RefSeq
and nanoCAGE mean lengths for all RefSeq mRNAs detected (E) and MTOR-sensitive genes (F). Green lines indicate a twofold difference in 5′ UTR length.
Gandin et al.
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EIF4A1 affects translation of MTOR-sensitive mRNAs with long,
but not short, 5′ UTRs
Depletion of EIF4E and EIF4A1 did not affect steady-state levels of
mRNAs with either long (CCND3, MCL1, BIRC5, and BCL2) or
short (ATP5O, ATP5G1, NDUFS6, and UQCC2) 5′ UTRs (Fig. 4B).
Under these conditions, the effects of EIF4E or EIF4A1 depletion
on global mRNA translation were comparable (Fig. 4C). Whereas
EIF4E down-regulation decreased translation of both long and
short 5′ UTR mRNAs, EIF4A1 depletion decreased translation of
mRNAs with long 5′ UTRs but only marginally altered translation
of mRNAs with short 5′ UTRs (Fig. 4D; Supplemental Fig. 11A).
Neither EIF4A1 nor EIF4E depletion altered distribution of
MTOR-insensitive mRNAs, e.g., ACTB (beta actin) and GAPDH
mRNAs (Fig. 4D; Supplemental Fig. 11A). Parallel results were ob-
tained using torin1 and hippuristanol (Supplemental Fig. 11B,C).
To further identify 5′ UTR features that render MTOR-sensi-
tive mRNAs largely insensitive to changes in EIF4A1 activity,
HEK293E cells were cotransfected with a Renilla (control) and a va-
riety of firefly (FF) luciferase reporters. FF reporters included IRF7 5′
UTR (IRF7[5′UTR]-FF), which is long and translated in an EIF4E-
dependent manner (Fig. 5A; Colina et al. 2008), ATP5O 5′ UTR
(ATP5O[5′UTR]-FF), which contains a 4-nt portion of the TISU el-
ement upstream of the initiation codon (Fig. 5B), and ATP5Owith
a complete TISU element, including a 5-nt portion distal to the ini-
tiation codon (ATP5O[TISU]-FF) (Fig. 5C). ATP5O(5′UTR)-FF there-
fore harbors a disrupted TISU element whereby the TISU element
sequence is substituted with GAGAA (the first 5 nt of the FF lucif-
erase ORF) downstream from the initiation codon. EIF4E down-
regulation strongly decreased expression of all three FF reporters.
In contrast, while EIF4A1 depletion strongly repressed luciferase
activity of IRF7-FF, it only had a moderate effect on ATP5O
(5′UTR)-FF (1.2-fold reduction vs. 6.6-fold observed in EIF4E-
depleted cells) and did not significantly affect luciferase activity
driven by ATP5O(TISU)-FF (Fig. 5A–C). Similar results were ob-
tained with torin1 and hippuristanol (Supplemental Fig. 12A–C).
As TISU element integrity did not appear to exert amajor influence
on EIF4A1- or EIF4E-sensitive translation (Fig. 5B,C; Supplemental
Figure 3. Mitochondria-related transcripts are enriched among MTOR-sensitive mRNAs with extremely short 5′ UTRs. (A) Enrichment of biological pro-
cesses in MTOR-sensitive mRNAs (from polysome-profiling) depending on nanoCAGE or RefSeq 5′ UTR lengths. Colors represent false discovery rates for
enrichments among short (blue) or long (yellow) 5′ UTRs. Both mean and largest peak 5′ UTR lengths from nanoCAGE were used as input. (B) A table of
genes from the mitochondria-related functions (identified in A) and their peak 5′ UTR lengths as determined by nanoCAGE. (C) A comparison of 5′ UTR
lengths ofMTOR-sensitivemitochondrial function or cell cycle/survival related genes. (D) Comparison of 5′ UTR lengths and the presence of a TISU element
in the indicated subsets of MTOR-sensitive mRNAs. (E) ATP5O is a subunit of complex V of the electron transport chain (ATP synthase) and is encoded by
mRNA with a putative TISU motif and an extremely short 5′ UTR (plot as in Fig. 2C).
5 ′ UTR features of MTOR-sensitive mRNAs
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Fig. 12B,C), we also monitored expres-
sion of FF luciferase driven by constructs
harboring the UQCC2 5′ UTR that does
not contain a TISU and NDUFS6 5′ UTR,
but which, similar to ATP5O(5′UTR)-FF,
only contains a portion of the TISU ele-
ment upstream of the initiation codon.
In both cases, results paralleled those ob-
served using the ATP5O reporters (Fig.
5D,E). Increasing secondary structure
and length by adding a stable stem–
loop structure (ATP5O[5′UTR]-SL-FF)
(Babendure et al. 2006) rendered the re-
porter both EIF4E- and EIF4A1-sensitive
(Fig. 5F). Importantly, under all condi-
tions listed above, control Renilla lucifer-
ase expression was largely insensitive to
both EIF4E and EIF4A1 (Supplemental
Figs. 13, 14). These data demonstrate
that translation of MTOR-sensitive
mRNAs with short 5′ UTRs is strongly
sensitive to EIF4E, but not EIF4A1, while
there is no obligatory requirement for an
intact TISU element.
Effects of MTOR-i and EIF4A-i on
translation are reflected by changes
in mitochondrial functions
mTORC1/EIF4EBP1/EIF4E axis bolsters
mitochondrial biogenesis and ATP
production by stimulating translation of
nuclear-encoded mRNAs with mito-
chondrial functions, including respirato-
ry chain components, e.g., ATP5O
(Morita et al. 2013). Here, nanoCAGE
identified a subset of MTOR-sensitive
mRNAs encoding mitochondria-related
proteins characterized by short 5′ UTRs
(Fig. 3B–D), which is consistent with
the findings that mRNAs encoding mito-
chondrial proteins frequently contain
TISU elements (Sinvani et al. 2015). As
translation of mRNAs with short 5′
UTRs is largely EIF4A-independent, we
postulated that short-term EIF4A1 inhi-
bition would have a lesser impact on mi-
tochondrial number and function as
compared to MTOR inhibition. To
directly compare the effects of MTOR-i
vs. EIF4A-i, we selected concentrations
of torin1 and silvestrol that comparably
suppressed HEK293E cell proliferation
(∼60% of control) (Fig. 6A, left panel).
After 16 h (a time period we previously
found to be suitable for detecting the im-
pact of MTOR inhibition on cell mito-
chondrial content and respiration
[Morita et al. 2013]), torin1, but not sil-
vestrol, reduced mitochondrial content
(Fig. 6A, right panel).
Figure 4. Expression of proteins encoded by mRNAs with long 5′ UTRs, but not those harboring short
5′ UTRs/TISU elements, is dependent on EIF4A1. (A) HEK293E and MCF7 cells were mock-transfected or
transfected with siRNA targeting EIF4A1 (si-EIF4A1), EIF4E (si-EIF4E), or scrambled control siRNA (Scr).
Levels of indicated proteins were determined 48 h post-transfection by Western blotting. ACTB served
as a loading control. Experiments were carried out in independent triplicate and quantified using densi-
tometry (Supplemental Fig. 9). (B) Total levels of indicatedmRNAs isolated from cells described in Awere
determined by RT-qPCR. Data were log2 transformed, and values obtained for indicated mRNAs were
normalized to those obtained for ACTB and to the mean expression per gene. (C) Subpolysomal, light
polysome, and heavy polysome fractions were obtained from cytosolic extracts from cells described in
A by ultracentrifugation using 5%–50% sucrose gradients. During fractionation, UV absorbance at
254 nm (Abs 254 nm) was continuously monitored to obtain absorbance tracings. Positions of 40S
and 60S ribosomal subunits, monosome (80S), and polysomes are indicated. (D) Amount of indicated
mRNAs in subpolysomal, light polysome, and heavy polysome fractions isolated from cells described
in C were determined by RT-qPCR. Experiments in panels B and D were carried out in independent du-
plicates, each consisting of a triplicate. Data are expressed as a percentage of a given mRNA in each frac-
tion. Bars represent SD values. P-values from one-way ANOVAs for heavy polysomes are indicated.
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In addition, although both torin1 (1.9-fold) and silvestrol
(1.4-fold) reduced mitochondrial respiration, the effect of torin1
was more substantial (Fig. 6B). Similar findings were obtained
using siRNA directed against EIF4E or EIF4A1 (Supplemental Fig.
15A). Furthermore, whereas EIF4A1 down-regulation slightly
elevated mitochondrial respiration relative to the control,
Figure 5. Translation of reportermRNAs harboring short 5′ UTRs is sensitive to EIF4E, but not EIF4A1. HEK293E cells were transfectedwith a control (Scr),
EIF4E (si-EIF4E), or EIF4A1 (si-EIF4A1) siRNAs and then transfected with firefly (FF) reporters harboring IRF7 5′ UTR (IRF7[5′UTR]-FF) (A), ATP5O 5′ UTR with a
proximal portion of TISU element before the initiation codon (ATP5O[5′UTR]-FF) (B), ATP5O 5′ UTR with a full TISU element (ATP5O[TISU]-FF) (C), UQCC2
5′ UTR (UQCC2[5′UTR]-FF) (D),NDUFS6 5′ UTR (NDUFS6[5′UTR]-FF) (E), or ATP5O 5′ UTR followed by a stem–loop structure (ATP5O[5′UTR]-SL-FF) (F). As
a control, cells were cotransfected with a Renilla reporter. Luminescence was monitored 48 h post-transfection. Data for firefly luminescence normalized to
Renilla luminescence were log2 transformed and normalized per replicate and to the mean of Scr (see Supplemental Fig. 14). Each experiment was per-
formed in independent triplicates, each consisting of three replicates, and data are shown as mean ± SD. RLU, relative light units. Schematics of the FF con-
structs are provided in the above histograms, and the positions of TISU and ORF of FF luciferase are indicated. P-values from one-way ANOVAs are shown.
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mitochondrial respiration was dramatically inhibited by EIF4E
depletion (Supplemental Fig. 15B). Therefore, short-term treat-
mentwithMTOR-i suppressesmitochondrial respirationmore dra-
matically than EIF4A-i, which is consistent with the disparity of
their effects on translation of mRNAs harboring short 5′ UTRs,
i.e., those encoding proteins involved in mitochondrial respira-
tion and functions.
EIF4A-i more dramatically induces apoptosis compared
to MTOR-i
Inhibition of the mTORC1/EIF4EBP1/EIF4E axis coincides with
down-regulation of proteins implicated in mitochondrial respira-
tory function (e.g., ATP5O, ATP5G1, UQCC2, NDUFS6) as well
as in the maintenance of the integrity of the mitochondrial outer
membrane (e.g., BCL2, MCL1, and BIRC5) (Fig. 4A). In contrast,
suppression of EIF4A1 activity selectively affects proteins that
maintain mitochondrial outer membrane integrity (Fig. 4A). This
explains why MTOR inhibitors mostly have a cytostatic effect
(Morita et al. 2015) and suggests that prolonged EIF4A1 inhibition
may trigger mitochondrial-mediated apoptosis by disrupting the
coordinated expression of proteins with mitochondrial metabolic
functions from those regulating mitochondrial structural integri-
ty. We therefore treated HEK293E cells with torin1 or silvestrol
for 72 h and measured mitochondrial membrane potential using
TMRE (tetramethylrhodamine, ethyl ester), a cell-permeant dye
that accumulates in active but not depolarized mitochondria
(Scaduto and Grotyohann 1999). As a positive control, cells were
treated with carbonyl cyanide 4-(trifluoromethoxy)phenylhydra-
zone (FCCP), a compound that depolarizes mitochondria (Fig.
7A). Exposure to silvestrol (72 h) markedly induced depolarization
ofmitochondria (Fig. 7A), and this correlatedwith induction of ap-
optosis as compared to control or torin1-treated cells (Fig. 7B).
Similar results were observed in nutrient-deprived cells depleted
of EIF4E or EIF4A1 (Supplemental Fig. 15C,D). These observations
indicate that suppression of translation of both long and short
5′ UTR MTOR-sensitive mRNAs by torin1 yields a predominantly
cytostatic outcome, whereas suppression of EIF4A1 function in-
duces apoptosis by exclusively inhibiting translation of mRNAs
with long 5′ UTRs encoding proteins that maintainmitochondrial
structural integrity.
MTOR inhibition increases autophagy (Kim and Guan 2015),
which eliminates depolarized mitochondria (Elmore et al. 2001;
Narendra et al. 2008; Twig et al. 2008). To determine whether
EIF4A1 inhibition affects autophagy, we monitored autophagic
flux by treating HEK293E cells with torin1 or silvestrol in the pres-
ence of chloroquine. Chloroquine prevents autophagosome-lyso-
some fusion causing accumulation of the autophagic markers
MAP1LC3A-II (LC3A-II) and MAP1LC3B-II (LC3B-II) (Klionsky
et al. 2012). While torin1 induced autophagy, as evidenced
by elevated levels of both MAP1LC3A-II and MAP1LC3B-II (Fig.
7C), silvestrol prevented accumulation of MAP1LC3A-II and
MAP1LC3B-II induced by chloroquine (Fig. 7C). By inhibiting
the lysosomal pH gradient, chloroquine impairs mTORC1 activa-
tion (Settembre et al. 2012), as illustrated by the decrease in the
phosphorylation of EIF4EBP1 and RPS6 after 16 h (Fig. 7C).
mTORC1 inhibition by chloroquine was partially reversed by sil-
vestrol (Fig. 7C). This is consistent with induction of mTORC1 in
response to EIF4A1 inhibition (Supplemental Fig. 10B; Galicia-
Vazquez et al. 2012). Therefore, in addition to inducingmitochon-
drial depolarization by altering mRNA translation, EIF4A-i pre-
vents induction of autophagy and elimination of depolarized
mitochondria.
Discussion
The advantage of ribosome- over polysome-profiling is that ribo-
some-profiling allows determination of ribosome positioning
on mRNA at single-nucleotide resolution (Ingolia et al. 2009).
However, there are anumberof challenges regarding interpretation
of ribosome-profiling (Guttman et al. 2013; Gerashchenko and
Gladyshev 2014; King and Gerber 2014; Lareau et al. 2014;
Pelechano et al. 2015). The relative performance of ribosome- vs.
polysome-profiling to study changes in translation efficiency also
remains unclear. mRNAs exhibit different translation properties,
in part conferred by their 5′ UTR features (Lodish 1974; Pelletier
and Sonenberg 1985; Koromilas et al. 1992; Graff et al. 2008;
Sonenberg and Hinnebusch 2009). We show that ribosome-profil-
ing studies should be interpreted with caution when simultane-
ously studying subclasses of mRNAs with disparate translation
properties. Ribosome-profiling efficiently identifies changes in
translation of highly abundant mRNAs that show large shifts in
polysome association (“class A mRNAs”) but is far less sensitive
in detecting less abundant mRNAs that shift less (“class B
mRNAs”). TOP mRNAs, upon MTOR inhibition, shift from heavy
polysomes to subpolysomal fractions (i.e., “class A mRNAs”),
whereas the majority of non-TOP mRNAs transit from intermedi-
ate-heavy to light polysomes (i.e., “class B mRNAs”) (Supple-
mental Fig. 1). In contrast, polysome-profiling captures the
translational changes in both classes of mRNAs. This may explain
discrepancies between the catalogs of MTOR-regulated mRNAs be-
tween ribosome- (Hsieh et al. 2012; Thoreen et al. 2012) vs. poly-
some-profiling (Larsson et al. 2012) studies. Consistently, while
ribosome-profiling led to the conclusion that the mTOR/
EIF4EBP1/EIF4E axis exclusively controls TOP and TOP-like
mRNA translation (Hsieh et al. 2012), the same group found that
Figure 6. Short-term (16 h) MTOR, but not EIF4A1 inhibition, decreases
mitochondrial number and respiration. (A) HEK293E cells were treated
with torin1 (250 nM), silvestrol (silv; 25 nM), or a vehicle (DMSO) control
for 16 h. Cells were counted to ensure that used concentrations of torin1
and silvestrol result in comparable inhibition of proliferation (left panel),
and mitochondrial mass was estimated by monitoring mean fluorescence
intensity of MitoTracker Green using flow cytometry (right panel). Data
were log2 transformed, normalized per replicate and to the mean of
DMSO, and are shown as means ± SD (n = 3). (B) HEK293E cells were treat-
ed with torin1 (250 nM), silvestrol (silv; 25 nM), or DMSO for 16
h. Mitochondrial respiration was assessed using a Clark electrode and pre-
sented as oxygen consumption rate (OCR). Data are shown as means of
four independent experiments (n = 4) ± SD in linear scale. P-values from
one-way ANOVAs calculated after log2 transformation and normalization
per replicate and to DMSO are indicated.
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EIF4E predominantly affects translation
of non-TOP mRNAs implicated in ROS
clearance using polysome-profiling
(Truitt et al. 2015).
Length, and plausibly other 5′ UTR
features, distinguishes two separate sub-
groups of MTOR-sensitive non-TOP
mRNAs that are functionally distinct.
First, there are those mRNAs harboring
long 5′ UTRs that encode survival- and
proliferation-promoting factors and are
strongly affected by EIF4E and EIF4A1.
Second, there are mRNAs that harbor
short 5′ UTRs/TISU elements, translated
in an EIF4E- but not an EIF4A1-sensitive
manner, enriched in those encoding
mitochondria-related proteins. In mam-
mals, EIF4A1 selectively stimulates trans-
lation of mRNAs that encode survival-
promoting proteins (e.g., BCL2, MCL1,
and BIRC5) without altering translation
of mitochondria-related short 5′ UTR
mRNAs (Rubio et al. 2014; Wolfe et al.
2014; Modelska et al. 2015). In yeast,
Ded1 (the ortholog of DDX3X in mam-
mals), rather than EIF4A, seems to act as
a major helicase that resolves secondary
5′ UTR structures (Sen et al. 2015).
Accordingly, in yeast, changes in EIF4A
activity uniformly affect translation of
most mRNAs, while modulation of
Ded1 primarily affects those with com-
plex 5′ UTRs (Sen et al. 2015). Several
features that distinguish yeast and mam-
malian EIF4A may explain these distinc-
tions. This includes differences in the
apparent stability of the eIF4F complex,
as EIF4E:EIF4G but not EIF4E:EIF4G:
EIF4A complexes can be purified from
yeast (Merrick 2015). Moreover, MTOR-
regulated auxiliary factor EIF4B (Raught
et al. 2004) significantly bolsters RNA-de-
pendent ATPase activity of mammalian
but not yeast EIF4A (Merrick 2015). It is
also plausible that helicases thought to
be required to unwind exceptionally
strong 5′ UTR secondary structures (e.g.,
DHX29 and DDX3X) (Parsyan et al.
2011)provide anadditional level ofdiver-
sity to MTOR-dependent translational
regulation.However, the signalingmech-
anisms that regulate DHX29 andDDX3X
function remain to be established.
Translation of TISU mRNAs is 5′
cap-dependent, resistant to glucose dep-
rivation but not to rapamycin, and re-
quires EIF1:EIF4G1 interaction (Sinvani
et al. 2015). We demonstrate that
MTOR-i or EIF4E depletion, but not inhi-
bition of EIF4A1, suppresses translation
of short 5′ UTR mRNAs (<30 nt). This
suggests that EIF4E is key for translation
Figure 7. Prolonged (72 h) inhibition of EIF4A1, but not MTOR, compromises mitochondrial integrity
and leads to apoptosis. (A) HEK293E cells were treated with torin1 (250 nM), silvestrol (silv; 25 nM), or a
vehicle (DMSO) for 72 h. Mitochondrial membrane potential (MMP) was analyzed by monitoring TMRE
fluorescence intensity by flow cytometry. As a control, cells were treated with FCCP (20 μM; 10 min) to
induce mitochondrial membrane depolarization. (Left panel) The flow cytometry histogram profiles of
unstained (control; black) and TMRE stained cells treated with FCCP (blue), a vehicle (DMSO; red), torin1
(orange), or silvestrol (silv; green). Cells harboring depolarized mitochondria (MMP−) were defined as
those with a TMRE signal equal to or less than the TMRE signal observed in FCCP-treated cells. (Middle
panel) Mean percentage (n = 3) of MMP− and MMP+ cells out of total viable cells (DAPI positive dead
cells were excluded). (Right panel) Overall TMRE emission expressed in arbitrary units (a.u.). Results
are presented as mean ± SD (n = 3). (B) HEK293E cells were treated as described in A, and apoptosis
was measured by flow cytometry using a FITC-Annexin V/PI staining. The fractions (%) of viable
(Annexin V−/PI−), early apoptotic (Annexin V+/PI−), late apoptotic (Annexin V+/PI low), and dead
(Annexin V+/PI high) cells are shown relative to the total cell population. Results represent means ± SD
(n = 3). P-values from one-way ANOVAs are shown. (C ) HEK293E cells were treated with torin1 (250
nM) or silvestrol (silv; 25 nM) in the presence or absence of chloroquine (CQ, 50 µM) for 4 and 16
h. Autophagy induction was monitored by the detection of MAP1LC3A/B lipidation (MAP1LC3A-II
and MAP1LC3B-II) using appropriate antibodies. The levels and phosphorylation status of indicated pro-
teins were monitored by Western blotting. ACTB served as a loading control. (D) Schematic representa-
tion of themodel. In addition to 5′ TOPmotif (TOPmRNAs), 5′ UTR features define two distinct subsets of
non-TOPmRNAs whose translation is stimulated by MTOR (mTOR; green): (1) mRNAs with long 5′ UTRs
whose translation is sensitive to both EIF4E (blue) and EIF4A1 (red), which encode pro-survival- (e.g.,
BCL2) and proliferation-promoting (e.g., CCND3) proteins, and (2) mRNAs with short 5′ UTRs whose
translation is sensitive to EIF4E (blue), but not EIF4A1 (red), which encode proteins with mitochondrial
functions (e.g., ATP5O). Whereas MTOR-i (mTOR-i; green) suppresses translation of both subsets of
mRNAs (1 and 2) leading to metabolic dormancy and cytostatic effect, EIF4A-i (red) selectively inhibits
translation of mRNAs with long 5′ UTRs (1), leading to apoptosis.
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of mRNAs containing short 5′ UTRs and TISU elements, which is
postulated to occur by facilitating recruitment of EIF4G1 and
which does not appear to be affected by EIF4A-i (Supplemental
Fig. 10C). Moreover, MTOR and EIF4E seem to regulate translation
ofATP5OmRNAs independently of the TISU element downstream
from the initiation codon, as well as translation of UQCC2mRNA
that comprises a short 5′ UTRwithout a TISU (Fig. 5B–D). This sug-
gests that the length of the 5′ UTR, rather than the presence of a
TISU, is the primary factor that determines EIF4E- versus EIF4A1-
sensitivity.
mTORC1 modulates translation of TOP mRNAs via LARP1
(Tcherkezian et al. 2014; Fonseca et al. 2015), whereas synthesis
of mitochondrial, proliferation- and survival-promoting proteins
is controlled by the EIF4EBP/EIF4E pathway (Larsson et al. 2012;
Morita et al. 2013). Notably, 5′ UTR features further separate
non-TOP MTOR-sensitive mRNAs into two distinctive groups
that differ in their EIF4A1-sensitivity. MTOR-i prevent translation
of short and long 5′ UTRmRNAs diminishingmitochondrial func-
tions, accompanied by metabolic quiescence and cytostasis,
whereas selective suppression of translation of a subset of long
but not short 5′ UTR mRNAs by EIF4A-i leads to mitochondrial
depolarization and apoptosis (Fig. 7D). These findings suggest
that mTORC1 deploys distinct effectors to modulate translation
of a variety of functional groups of mRNAs far beyond TOP
mRNAs to regulate cellular homeostasis in response to a variety
of extracellular stimuli and intracellular cues.
In addition to the differential effects of MTOR-i and EIF4A-i
on translation, it is likely that these compounds exert opposing
metabolic effects. MTOR-i reduce mitochondrial ATP production
while suppressing ATP consumption by anabolic processes and
stimulating autophagy, which facilitates the replenishment of a
variety of cellular building blocks (Morita et al. 2013; Albert and
Hall 2014; Shimobayashi and Hall 2014). Although EIF4A-i may
also decrease ATP consumption by the translational machinery,
they are likely to stimulate other anabolic processes via increasing
mTORC1 activity (Supplemental Fig. 10B; Galicia-Vazquez et al.
2012). Contrary to previous reports, the effects of silvestrol on
tumor cell viability cannot be accounted for by modulation of
p-EIF4E status (Chu et al. 2015). EIF4A-i may therefore avoid com-
pensatory effects seen with MTOR-i, resulting in a more effective
precipitation of mitochondrial dysfunction and cell death.
Indeed, unlike MTOR-i, silvestrol attenuated autophagy, which is
considered a major mechanism for nutrient replenishment and
clearance of depolarized mitochondria (Elmore et al. 2001;
Narendra et al. 2008; Twig et al. 2008).
In conclusion, important 5′ UTRmRNA variations determine
MTOR-sensitivity. Current databases do not always accurately re-
flect the 5′ UTR features, while certain analytical biases currently
limit the accuracy of ribosome-profiling techniques for monitor-
ing changes in translational efficiency. Finally, two functionally
distinct subgroups of non-TOP MTOR-sensitive mRNAs provide
the molecular basis for the superior anti-neoplastic effects of
EIF4A-i over MTOR-i.
Methods
Simulations
Distributions of ribosome associations were obtained by sampling
from a normal distribution. These were then converted to mean
number of ribosomes (equivalent to ribosome-profiling) or propor-
tions ofmRNAs associatedwithmore than three ribosomes (equiv-
alent to polysome-profiling), followed by calculation of fold
changes and P-values that were compared across polysome- and ri-
bosome-profiling. Detailed protocols for simulations are provided
in the Supplemental Material.
Preparation of nanoCAGE libraries and analysis
of nanoCAGE data
NanoCAGE libraries were prepared and analyzed as described
(Salimullah et al. 2011) but with a number of modifications that
are described in detail in the Supplemental Material.
Cell culture, inhibitors, antibodies, and RNAi
HEK293E and MCF7 cells (ATCC) were maintained in Dulbecco’s
modified Eagle’s medium (DMEM; Wisent) and RPMI-1640
(Wisent), respectively, supplemented with 10% fetal bovine serum
(Wisent), 1% penicillin/streptomycin (Wisent), and 1% L-gluta-
mine (Wisent). Where indicated, cells were treated with 250 nM
torin1 (Tocris), 1 μM hippuristanol, and 25 nM silvestrol or the
same volume of vehicle (DMSO). Lists of siRNAs, shRNAs antibod-
ies, and dilutions that were used in Western blots are provided in
the Supplemental Material.
Polysome profiles and RT-qPCR
MCF7 cells were seeded in a 15-cm Petri dish, harvested at 80%
confluency, and lysed in hypotonic lysis buffer (5 mM Tris HCl,
pH 7.5, 2.5 mM MgCl2, 1.5 mM KCl, 100 μg/mL cycloheximide,
2 mM DTT, 0.5% Triton, 0.5% sodium deoxycholate). Polysome-
profiling was carried out as described (Gandin et al. 2014). RT-
qPCR was performed as previously described (Miloslavski et al.
2014). Fractions were collected as described in Gandin et al.
(2014), and RNA was extracted using TRIzol according to the
manufacturer’s instructions. RT and qPCR were performed by
SuperScript III Reverse Transcriptase and Fast SYBR Green
Mastermix (Invitrogen), respectively. Experiments were done at
least in independent duplicates (n = 2) whereby every sample was
analyzed in a technical triplicate. Analyses were carried out using
a relative standard curve method as described in http://www3.
appliedbiosystems.com/cms/groups/mcb_support/documents/
generaldocuments/cms_040980.pdf. Primers are listed in the
Supplemental Material.
Statistical analysis
We performed one-way or two-way ANOVA in R (R Core Team
2014) as indicated in the figure legends.
Data access
nanoCAGE data from this study have been submitted to the NCBI
Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/
geo/) under accession number GSE77033.
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